Facebook Linkedin Mail Twitter Youtube
  • Home
  • Research
  • Blog
  • TRIPS Flexibilities Database
  • Other Resources
    • Covid-19
    • Tools
      • Introduction
      • Model Government Use Licences
      • Model Uses of Paragraph 7 or “LDC Waiver”
      • Special Compulsory Licences for Export of Medicines
      • Options for Regional Economic Communities
      • Voluntary Licences
    • Useful Links
  • About
Search
Menu

Explore the website

Medicines Law & PolicyResearch and resources on intellectual property and health
Twitter
Linkedin
Facebook
Medicines Law & Policy
Research and resources
on intellectual property and health.
Contact Us
Subscribe

Subscribe to our newsletter and never miss a post!

* indicates required

Medicines Law & Policy will use the information you provide to keep you up-to-date when we post new research and insight. You can change your mind about receiving our newsletter any time by clicking the unsubscribe link in the footer of any email you receive from us. We will treat your information with respect. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Menu

Explore the website

  • Home
  • Research
  • Blog
  • TRIPS Flexibilities Database
  • Other Resources
    • Covid-19
    • Tools
      • Introduction
      • Model Government Use Licences
      • Model Uses of Paragraph 7 or “LDC Waiver”
      • Special Compulsory Licences for Export of Medicines
      • Options for Regional Economic Communities
      • Voluntary Licences
    • Useful Links
  • About

Medicines Law & Policy

Facebook
Linkedin
Twitter

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.

  • Home
  • Research
  • Blog
  • TRIPS Flexibilities Database
  • Tools
  • Covid-19
  • Useful Links
  • About
  • TRIPS Flexibilities Database
  • Other resources

Never miss a post! Sign up for ML&P's mailing list by entering your information below. The list will only be used to inform you of new content (messages are sent approximately once a month).

* indicates required






Medicines Law & Policy will use the information you provide to keep you up-to-date when we post new research and insight. You can change your mind about receiving our newsletter any time by clicking the unsubscribe link in the footer of any email you receive from us. We will treat your information with respect. By clicking below, you agree that we may process your information in accordance with these terms. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

 
 

This work is licensed under Creative Commons. You are free to share, with attribution and without changes, for non-commercial purposes.